Sort by
Refine Your Search
-
seeking a full-time (1.0 FTE) Postdoctoral Research Fellow for a one-year (renewable) appointment. The individual will have outstanding quantitative skills to lead analyses on our ageing research program
-
cross-national exchange and collaboration. The program is open to eligible individuals from the following countries: Australia, Canada, France, Germany, the Netherlands, New Zealand, Norway, Singapore
-
degree (M.D., Ph.D. or equivalent) and must be in a research-oriented postdoctoral training program at an academic, government, or non-profit research institution. Applicants must have more than two years
-
, single-cell analysis capabilities, opportunities to partner with the country's strongest concentration of computational neuroscientists and much more. Fellows also enjoy the institute's extensive portfolio
-
at the Swiss Federal Institute of Technology Zurich (ETH) . The directorate consists of Prof. Dr. Angelika Steger, Full Professor for Computer Science at ETH Zurich, Prof. Dr. Heidi Wunderli-Allenspach, Rector
-
, StrokeCog can leverage CANTRAIN’s online tools, learning-management systems, training programs and its college of mentors. Applicants apply to the StrokeCog fellowship program through the CANTRAIN portal
-
The Postdoctoral Fellowship program provides support for highly qualified postdoctoral fellows to engage in research that is in an area of clear relevance to arthritis and Arthritis Society Canada’s
-
Global Affairs Canada For further information on the program, please visit Interchange Canada Who can apply: Permanent residents in Canada and Canadian citizens in Canada.* * As of January 13, 2025
-
Fellowships in research areas covered by the Euratom Research and Training Programme , researchers need to be nationals or long-term residents of an EU Member State or a Euratom Associated Country. The
-
Program. The lab also actively collaborates with national and international partners in the fields of: Hereditary cancer biology; Oriented cell division mechanisms; Pediatric leukemia and breast cancer